Paola Cattaneo

Paola Cattaneo

Auto-generated profile, based on publicly available information

Paola Cattaneo

Institute of Cardiovascular Regeneration, Goethe University, Frankfurt am Main, Germany (V.L., A.F., L.S.T., S.P., D.M., S.D., P.C., N.G.-C.).

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2017 in Cell Stem Cell
Verified
Journal Article
Closed access
NGNuno Guimarães-Camboa
Nuno Guimarães-Camboa
PCPaola Cattaneo
Paola Cattaneo
YSYunfu Sun
Yunfu Sun
TMThomas Moore-Morris
Thomas Moore-Morris
YGYusu Gu
Yusu Gu
SESylvia M. Evans
Sylvia M. Evans

27 November 2013 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
RPRoberto Papait
Roberto Papait
PCPaola Cattaneo
Paola Cattaneo
PKPaolo Kunderfranco
Paolo Kunderfranco
CGCarolina Greco
Carolina Greco
PCPierluigi Carullo
Pierluigi Carullo
Gerolama CondorelliGerolama Condorelli
Gerolama Condorelli
Significance: Cardiac failure is a leading cause of mortality worldwide and a major financial burden for healthcare systems. New tools for understanding cardiovascular disease and developing better therapeutic approaches are therefore needed. To this end, transcriptional regulation has been extensively studied in cardiac hypertrophy and failure, but there is still a lack of understanding of the epigenetic framework in which transcription factors act. Our report adds significant knowledge to the field because we demonstrate, in vivo, that a complex and specific epigenetic signature regulates gene expression by modulating promoters and enhancers, a large number of which have been described here. These findings advance our understanding of the mechanisms underlying this pathology.

1 June 2015 in Developmental Cell
Verified
Journal Article
Closed access
NGNuno Guimarães-Camboa
Nuno Guimarães-Camboa
JSJennifer Stowe
Jennifer Stowe
IAIvy Aneas
Ivy Aneas
NSNoboru Sakabe
Noboru Sakabe
PCPaola Cattaneo
Paola Cattaneo
AZAlex Zambon
Alex Zambon

28 December 2009 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
CFChiara Francavilla
Chiara Francavilla
PCPaola Cattaneo
Paola Cattaneo
VBVladimir Berezin
Vladimir Berezin
EBElisabeth Bock
Elisabeth Bock
DADiletta Ami
Diletta Ami
Ugo CavallaroUgo Cavallaro
Ugo Cavallaro
Neural cell adhesion molecule (NCAM) associates with fibroblast growth factor (FGF) receptor-1 (FGFR1). However, the biological significance of this interaction remains largely elusive. In this study, we show that NCAM induces a specific, FGFR1-mediated cellular response that is remarkably different from that elicited by FGF-2. In contrast to FGF-induced degradation of endocytic FGFR1, NCAM promotes the stabilization of the receptor, which is recycled to the cell surface in a Rab11- and Src-dependent manner. In turn, FGFR1 recycling is required for NCAM-induced sustained activation of various effectors. Furthermore, NCAM, but not FGF-2, promotes cell migration, and this response depends on FGFR1 recycling and sustained Src activation. Our results implicate NCAM as a nonconventional ligand for FGFR1 that exerts a peculiar control on the intracellular trafficking of the receptor, resulting in a specific cellular response. Besides introducing a further level of complexity in the regulation of FGFR1 function, our findings highlight the link of FGFR recycling with sustained signaling and cell migration and the critical role of these events in dictating the cellular response evoked by receptor activation.

20 July 2015 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
XLXingqun Liang
Xingqun Liang
QZQingquan Zhang
Qingquan Zhang
PCPaola Cattaneo
Paola Cattaneo
SZShaowei Zhuang
Shaowei Zhuang
XGXiaohui Gong
Xiaohui Gong
SESylvia M. Evans
Sylvia M. Evans
The sinoatrial node (SAN) maintains a rhythmic heartbeat; therefore, a better understanding of factors that drive SAN development and function is crucial to generation of potential therapies, such as biological pacemakers, for sinus arrhythmias. Here, we determined that the LIM homeodomain transcription factor ISL1 plays a key role in survival, proliferation, and function of pacemaker cells throughout development. Analysis of several Isl1 mutant mouse lines, including animals harboring an SAN-specific Isl1 deletion, revealed that ISL1 within SAN is a requirement for early embryonic viability. RNA-sequencing (RNA-seq) analyses of FACS-purified cells from ISL1-deficient SANs revealed that a number of genes critical for SAN function, including those encoding transcription factors and ion channels, were downstream of ISL1. Chromatin immunoprecipitation assays performed with anti-ISL1 antibodies and chromatin extracts from FACS-purified SAN cells demonstrated that ISL1 directly binds genomic regions within several genes required for normal pacemaker function, including subunits of the L-type calcium channel, Ank2, and Tbx3. Other genes implicated in abnormal heart rhythm in humans were also direct ISL1 targets. Together, our results demonstrate that ISL1 regulates approximately one-third of SAN-specific genes, indicate that a combination of ISL1 and other SAN transcription factors could be utilized to generate pacemaker cells, and suggest ISL1 mutations may underlie sick sinus syndrome.

1 February 2016 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
TMThomas Moore-Morris
Thomas Moore-Morris
PCPaola Cattaneo
Paola Cattaneo
MPMichel Puceat
Michel Puceat
SESylvia M. Evans
Sylvia M. Evans